Kotyark Industries Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Kotyark Industries Ltd is ₹ 364.45 as of 19 Mar 15:30 . The P/E Ratio of Kotyark Industries Ltd is 20.3 as of March 2023 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2023 . The Market Cap of Kotyark Industries Ltd is ₹ 263.51 crore as of March 2023 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2023 . The Dividend Payout of Kotyark Industries Ltd changed from 19.14 % on March 2022 to 62.02 % on March 2025 . This represents a CAGR of 34.17% over 4 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Kotyark Industries Ltd

Kotyark Industries Limited was originally incorporated on December 30, 2016 as 'Kotyark Industries Private Limited' with the Registrar of Companies.
Further, the status of the Company got converted into Public Limited and the name was changed from 'Kotyark Industries Private Limited' to 'Kotyark Industries Limited' and a fresh Certificate of Incorporation w.e.f.
August 05, 2021 was issued by the Registrar of Companies, Ahmedabad.
The Company operate manufacturing of bio fuel plants at Swaroopgunj, in Sirohi District of Rajasthan.
It works a well-diversified customer base including Oil Marketing Companies (OMCs) like Indian Oil Corporation Limited, bulk buyers being Transport Contractor, Mining Companies etc. The Company commenced manufacturing of different variants of biofuels in May, 2019.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Kotyark Industries Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Kotyark Industries Ltd or Sheel Biotech Ltd?

Market cap of Kotyark Industries Ltd is 374 Cr while Market cap of Sheel Biotech Ltd is 99 Cr

What are the key factors driving the stock performance of Kotyark Industries Ltd and Sheel Biotech Ltd?

The stock performance of Kotyark Industries Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kotyark Industries Ltd and Sheel Biotech Ltd?

As of March 19, 2026, the Kotyark Industries Ltd stock price is INR ₹364.45. On the other hand, Sheel Biotech Ltd stock price is INR ₹48.85.

How do dividend payouts of Kotyark Industries Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Kotyark Industries Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.